Notice Number: NOT-HL-19-696
Release Date: April 24, 2019
National Heart, Lung, and Blood Institute (NHLBI)
On April 11, 2019, the NHLBI issued the Funding Opportunity Announcement (FOA) RFA-HL-20-005, entitled "Late-Stage Implementation Research Addressing Hypertension in Low- and Middle-Income Countries: Scaling Up Proven-Effective Interventions (UG3/UH3 Clinical Trial Optional)".
A pre-submission technical assistance webinar for RFA-HL-20-005 is scheduled for Tuesday, May 21 at 9:00 a.m. EDT. The webinar will include a review of the purpose and objectives of this FOA, application and peer review requirements, and budget considerations.
All prospective applicants are invited to attend and are strongly encouraged to send relevant questions prior to the webinar in order to maximize the use of time. Specific questions should be sent via email to firstname.lastname@example.org no later than 48 hours prior to the webinar.
Session date and time: Tuesday, May 21, 2019 9:00 - 10:00 am EDT
Join Webex Meeting
Event number: 622 085 584
Event password: gacd
Event address for attendees: https://nih.webex.com/nih/onstage/g.php?MTID=e3feddae54b2d11196379a548c25133c1
Join the Audio Conference
Call-in toll number (US/Canada): 1-650-479-3208
Global call-in numbers: https://nih.webex.com/nih/globalcallin.php?serviceType=EC&ED=809509702&tollFree=0
Access code: 622 085 584
Participation in this webinar, although encouraged, is optional and is not required for the submission of an application in response to RFA-HL-20-005.
This Notice also provides information regarding the availability of Frequently Asked Questions (FAQs) to address common questions from potential applicants regarding RFA-HL-20-005, which can be found at: https://www.nhlbi.nih.gov/grants-and-training/funding-opportunities-and-contacts/all-funding-opportunity-announcements/rfa-hl-20-005.
All applicants are encouraged to review the FAQs prior to submitting their application. The FAQs may be updated, as needed. Applicants are encouraged to check back often for updates to the FAQs throughout the application submission period.
Please direct all inquiries to:
LeShawndra N. Price, Ph.D.
National Heart, Lung, and Blood Institute
Claudia Moy, Ph.D.
National Institute of Neurological Disease and Stroke